Agenus Inc
NASDAQ:AGEN 3:59:55 PM EDT
| Market Cap (Intraday) | 1.18B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $5.31 |
| 50-Day MA | $5.09 |
| 200-Day MA | $3.92 |
Agenus Inc Stock, NASDAQ:AGEN
3 Forbes Road, Lexington, Massachusetts 02421-7305
United States of America
Phone: +1.781.674.4400
Number of Employees: 359
Description
Agenus, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava in March 31, 1994 and is headquartered in Lexington, MA.